Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accordion Pill carbidopa/levodopa versus immediate-release Sinemet in fluctuating Parkinson's disease
MOH_2017-05-08_000390Phase 3Active, not recruiting
- Sponsor
- Intec Pharma Ltd.
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carbidopa and levodopa in Parkinson's disease (PD) (2 arms), sponsored by Intec Pharma Ltd. Primary endpoint: Not reported. Started Feb 2016; status: active, not recruiting.
02
Drugs
carbidopalevodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on MOH_2017-05-08_000390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-08_000390.